Dynamic Investigation of Sensitivity and Action Mechanism of Antitumor Drug


Article Preview

Dynamic responses of A549 cells to epirubicin (EPI), daunorubicin (DNR), cisplatin (DDP) and carboplatin (CBP) were monitored by real-time cell electronic sensing (RT-CES) system. A new defined parameter, the detachment duration, was defined to quantitatively characterize drug-cell action mechanism. For DNR, there were two different linear dependent regions of the detachment duration. The rate constant of DNR in lower concentration region (20.4±2.0 h/μM) is much larger than that in higher concentration region (3.2±0.1 h/μM). Moreover, the rate constant of DNR in lower concentration region is close to that of EPI in higher concentration region (17.5±0.5 h/μM). Similar observation occurred in the case of DDP and CBP treatment, and the rate constant is (2.8±0.4)×10 h/μM and (4.6±1.3)×10 h/μM respectively. Taken together, A549 cells are more sensitive to DNR than EPI and to DDP than CBP. This study provides new insight into cell-drug interaction. RT-CES system may play important role in future drug screening, mechanism exploration and clinical therapy.



Advanced Materials Research (Volumes 343-344)

Edited by:

David Wang






X. Liu et al., "Dynamic Investigation of Sensitivity and Action Mechanism of Antitumor Drug", Advanced Materials Research, Vols. 343-344, pp. 476-482, 2012

Online since:

September 2011




[1] S.O. Kelley, E. M. Boon, J. K. Barton, N. M. Jackson and M. G. Hill, Single-base mismatch detection based on charge transduction through DNA, Nucl. Acids Res., vol. 27, no. 23, pp.4830-4836, October (1999).

DOI: 10.1093/nar/27.24.4830

[2] S. O. Kelley, N. M. Jackson, M. G. Hill and J. K. Barton, Long-range electron transfer through DNA films, Angew. Chem. Int. Ed., vol. 38, no. 7, p.941–947, April (1999).

DOI: 10.1002/(sici)1521-3773(19990401)38:7<941::aid-anie941>3.0.co;2-7

[3] J. C. Zhou, The Clinic Analysis of Anticancer Drugs, Chemical Industry Press, Beijing, China, (2001).

[4] J. Lokich, N. Anderson, Carboplatin versus cisplatin in solid tumors: An analysis of the literature, Ann. Oncol., vol. 9, no. 1, pp.13-21, January (1998).

DOI: 10.1023/a:1008215213739

[5] K. Solly, X. B. Wang, X. Xu, B. Strulovici and W. Zheng, Application of real-time cell electronic sensing (RT-CES) technology to cell-based assays, Assay Drug Dev. Technol., vol. 2, no. 4, pp.363-372, August (2004).

DOI: 10.1089/1540658041850544

[6] J. Z. Xing, L. J. Zhu, J. A. Jackson, S. Gabos, X. J. Sun, X. B. Wang, et al, Dynamic monitoring of cytotoxicity on microelectronic sensors, Chem. Res. Toxicol, vol. 18, no. 2, pp.154-161, February (2005).

DOI: 10.1021/tx049721s

[7] J. M. Atienza, J. Zhu, X. B. Wang, X. Xu and Y. Abassi, Dynamic monitoring of cell adhesion and spreading on microelectronic sensor arrays, J. Biomol. Screen, vol. 10, no. 8, pp.795-805, December (2005).

DOI: 10.1177/1087057105279635

[8] J. M. Boyd, L. Huang, L. Xie, B. Moe, S. Gabos and X. F. Li, A cell-microelectronic sensing technique for profiling cytotoxicity of chemicals, Analytica Chimica Acta, vol. 615, no. 1, pp.80-87, May (2008).

DOI: 10.1016/j.aca.2008.03.047

[9] L. Huang, L. Xie, J. M. Boyd and X. F. Li, Cell-electronic sensing of particle-induced cellular responses, Analyst, vol. 133, no. 5, pp.643-648, May (2008).

DOI: 10.1039/b714384b

[10] Y. K. Ge, T. L. Deng and X. X. Zheng, Dynamic monitoring of changes in endothelial cell-substrate adhesiveness during leukocyte adhesion by microelectrical impedance assay, Acta. Biochim. Biophys. Sin., vol. 41, no. 3, pp.256-262, March (2009).

DOI: 10.1093/abbs/gmp009

[11] S. Chikayama, S. Kimura, Y. Kobayashi, T. Abe, T. Maekawa and M. Kondo, Effects of daunorubicin on cell growth, cell cycle and induction of apoptosis in HL-60 cells, Haematologia, vol. 29, no. 2, pp.115-121, (1998).

[12] M. G. Come, A. Skladanowski, A. K. Larsen and G. Laurent, Dual mechanism of daunorubicin-induced cell death in both sensitive and MDR-resistant HL-60 cells, Br. J. Cancer, vol. 79, no. 7-8, pp.1090-1097, March (1999).

DOI: 10.1038/sj.bjc.6690174

[13] K. Lotfi, A. L. Zackrisson and C. Peterson, Comparison of idarubicin and daunorubicin regarding intracellular uptake, induction of apoptosis, and resistance, Cancer Lett., vol. 178, no. 2, pp.141-149, April (2002).

DOI: 10.1016/s0304-3835(01)00824-2

[14] R. J. Knox, F. Friedlos, D. A. Lydall and J. J. Roberts, Mechanism of cytotoxicity of anticancer platinum drugs: Evidence that cis-diam-minedichloroplatinum (II) and cis-diammine (l, l-cyclobutane-diacarboxylate) platinum (II) differ only in kinetics of their interaction with DNA, Cancer Res., vol. 46, no. 4 pt 2, pp.1972-1979, April (1986).

DOI: 10.1016/s0277-5387(97)00477-4

In order to see related information, you need to Login.